Kohlruss, Meike
Reiche, Magdalena
Jesinghaus, Moritz
Grosser, Bianca
Slotta-Huspenina, Julia
Hapfelmeier, Alexander
Bauer, Lukas
Novotny, Alexander
Weichert, Wilko
Keller, Gisela
Funding for this research was provided by:
Deutsche Krebshilfe (70112177, 70112177, No. 70112177)
Article History
Received: 9 May 2018
Accepted: 6 August 2018
First Online: 22 August 2018
Competing Interests
: W.W. has a consulting role for Novartis, Pfizer, BMS, MSD, Roche, Boehringer Ingelheim and has research funding from Roche, Astra Zeneca and Novartis. All remaining authors have declared no competing interests.